Key Documents

View All Documentation

Thioguanine

Name: Thioguanine
Brand: USP
Price: 10300 CZK

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

6-Thioguanine, 2-Amino-6-mercaptopurine, 2-Amino-6-purinethiol

Select a Size

Change View

Pack Size	SKU	Availability	Price
200 mg		Please contact Customer Service for Availability	CZK 10,300.00

About This Item

Empirical Formula (Hill Notation):

C₅H₅N₅S

CAS Number:

154-42-7

Molecular Weight:

167.19

UNSPSC Code:

41116107

NACRES:

NA.24

PubChem Substance ID:

329751279

MDL number:

MFCD00233553

Beilstein/REAXYS Number:

157765

CZK 10,300.00

Please contact Customer Service for Availability

Request a Bulk Order

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

grade

pharmaceutical primary standard

API family

thioguanine, tioguanine

manufacturer/tradename

USP

mp

≥300 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

NC1=Nc2nc[nH]c2C(=S)N1

InChI

1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)

InChI key

WYWHKKSPHMUBEB-UHFFFAOYSA-N

Gene Information

human ... IMPDH1(3614), IMPDH2(3615)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Analytical Reference Materials for Pharma QC

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item	BP878	PHR3250	1392002
USP 1660000 Thioguanine	BP878 Tioguanine	Supelco PHR3250 Thioguanine	USP 1392002 Mercaptopurine
manufacturer/tradename USP	manufacturer/tradename BP	manufacturer/tradename -	manufacturer/tradename USP
format neat	format neat	format -	format neat
grade pharmaceutical primary standard	grade pharmaceutical primary standard	grade certified reference material, pharmaceutical secondary standard	grade pharmaceutical primary standard
application(s) pharmaceutical (small molecule)	application(s) pharmaceutical pharmaceutical small molecule	application(s) pharmaceutical	application(s) pharmaceutical (small molecule)
API family thioguanine, tioguanine	API family thioguanine, tioguanine	API family tioguanine, thioguanine	API family mercaptopurine
mp ≥300 °C (lit.)	mp ≥300 °C (lit.)	mp ≥300 °C (lit.)	mp >300 °C (lit.)

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Thioguanine USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Thioguanine Tablets

Biochem/physiol Actions

Ribosylated and phosphorylated by the same pathway as natural purine bases; as the nucleotide, inhibits a variety of cellular processes involved in nucleic acid synthesis. Has a long history as an effective treatment of leukemia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Other Notes

Sales restrictions may apply.

pictograms

GHS06

signalword

Danger

hcodes

H301

pcodes

P301 + P330 + P331 + P310

Hazard Classifications

Acute Tox. 3 Oral

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Anti-metastatic activity of the tumor vascular targeting agent NGR-TNF.

Paola Di Matteo et al.

Clinical & experimental metastasis, 32(3), 289-300 (2015-02-05)

Tumor vessels are an attractive target for cancer therapy, including metastasis treatment. Angiogenesis inhibitors targeting the VEGF signalling pathway have proven to be efficacious in preclinical cancer models and in clinical trials. However, angiogenesis inhibition concomitantly elicits tumor adaptation and

Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection.

Chenglong Sun et al.

Journal of immunology (Baltimore, Md. : 1950), 194(4), 1819-1831 (2015-01-18)

Herpesviruses are DNA viruses harboring the capacity to establish lifelong latent-recurrent infections. There is limited knowledge about viruses targeting the innate DNA-sensing pathway, as well as how the innate system impacts on the latent reservoir of herpesvirus infections. In this

Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.

Lynne Lennard et al.

British journal of haematology, 169(2), 228-240 (2014-12-03)

The impact of thiopurine methyltransferase (TPMT) genotype on thiopurine dose intensity, myelosuppression and treatment outcome was investigated in the United Kingdom childhood acute lymphoblastic leukaemia (ALL) trial ALL97. TPMT heterozygotes had significantly more frequent cytopenias and therefore required dose adjustments

TGFβ induces "BRCAness" and sensitivity to PARP inhibition in breast cancer by regulating DNA-repair genes.

Liang Liu et al.

Molecular cancer research : MCR, 12(11), 1597-1609 (2014-08-12)

Transforming growth factor beta (TGFβ) proteins are multitasking cytokines, in which high levels at tumor sites generally correlate with poor prognosis in human patients with cancer. Previously, it was reported that TGFβ downregulates the expression of ataxia telangiectasia-mutated (ATM) and

A therapeutic microparticle-based tumor lysate vaccine reduces spontaneous metastases in murine breast cancer.

Brett P Gross et al.

The AAPS journal, 16(6), 1194-1203 (2014-09-17)

Metastatic breast cancer is currently incurable, and available therapies are associated with severe toxicities. Induction of protective anti-tumor immunity is a promising therapeutic approach for disseminated breast cancer, as immune responses are (i) systemic; (ii) antigen-specific; and (iii) capable of

View All Related Papers

Global Trade Item Number

SKU	GTIN
1660000-200MG	04061833833445

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service